Pharmacogenetic profiling and clinical outcome of patients (pts) with advanced gastric cancer (AGC) treated with S-1 monotherapy

被引：0
|
作者：
Ichikawa, W. [1 ]
Takahashi, T. [1 ]
Sasaki, Y. [1 ]
机构：
[1] Saitama Med Sch, Iruma, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4600
引用
收藏
页数：1
相关论文
共 50 条
  • [41] S-1-based therapy versus S-1 monotherapy in advanced gastric cancer: a meta-analysis
    Wu, Jun-Rong
    Tang, Wei-Zhong
    Chen, Xi
    Xie, Yan-Tong
    Chen, Si-Yuan
    Peng, Qi-Liu
    Xie, Li
    Deng, Yan
    Li, Tai-Jie
    He, Yu
    Wang, Jian
    Li, Shan
    Qin, Xue
    TUMOR BIOLOGY, 2014, 35 (04) : 3283 - 3293
  • [42] Efficacy of S-1 for advanced gastric cancer (AGC) in clinical practice: Results from a nation-wide post-marketing survey in 3801 patients
    Baba, H
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Watanabe, M
    Maehara, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 369S - 369S
  • [43] Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer
    Yamauchi, Junichi
    Kanai, Masashi
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Yazumi, Shujiro
    Kami, Kazuhiro
    Kawaguchi, Yoshiya
    Yasuda, Hiroyasu
    Kitano, Toshiyuki
    Misawa, Akiko
    Ishiguro, Hiroshi
    Yoshikawa, Kiyotsugu
    Yanagihara, Kazuhiro
    Fukushima, Masanori
    Doi, Ryuichiro
    Chiba, Tsutomu
    PANCREAS, 2008, 36 (03) : 327 - 328
  • [44] A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G
    Makiyama, Akitaka
    Shoji, Hirokazu
    Kawakami, Hisato
    Tamura, Takao
    Sugiyama, Keiji
    Hara, Hiroki
    Nagase, Michitaka
    Nishikawa, Kazuo
    Esaki, Taito
    Izawa, Naoki
    Nakamura, Masato
    Ando, Takayuki
    Miura, Yuji
    Narita, Yukiya
    Shimokawa, Mototsugu
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Hyodo, Ichinosuke
    Muro, Kei
    ANNALS OF ONCOLOGY, 2023, 34 : S1390 - S1390
  • [45] Phase 1/2 Clinical Study of Irinotecan and Oral S-1 (IRIS) in Patients with Advanced Gastric Cancer
    Komatsu, Yoshito
    Yuki, Satoshi
    Fuse, Nozomu
    Kato, Takashi
    Miyagishima, Takuto
    Kudo, Mineo
    Kunieda, Yasuyuki
    Tateyama, Miki
    Wakahama, Osamu
    Meguro, Takashi
    Sakata, Yuh
    Asaka, Masahiro
    ADVANCES IN THERAPY, 2010, 27 (07) : 483 - 492
  • [46] Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer
    Yoshito Komatsu
    Satoshi Yuki
    Nozomu Fuse
    Takashi Kato
    Takuto Miyagishima
    Mineo Kudo
    Yasuyuki Kunieda
    Miki Tateyama
    Osamu Wakahama
    Takashi Meguro
    Yuh Sakata
    Masahiro Asaka
    Advances in Therapy, 2010, 27 : 483 - 492
  • [47] Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer
    Zhang, Zhan-Dong
    Kong, Ye
    Yang, Wei
    Zhang, Bin
    Zhang, Yong-Lei
    Ma, Er-Min
    Liu, Hong-Xing
    Chen, Xiao-Bin
    Hua, Ya-Wei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [48] Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer
    Zhan-Dong Zhang
    Ye Kong
    Wei Yang
    Bin Zhang
    Yong-Lei Zhang
    Er-Min Ma
    Hong-Xing Liu
    Xiao-Bin Chen
    Ya-Wei Hua
    World Journal of Surgical Oncology, 12
  • [49] Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer
    Sakaguchi Y.
    Kabashima A.
    Okita K.
    Ojima Y.
    Yamamura S.
    Nishizaki T.
    Tashiro H.
    Matsusaka T.
    Gastric Cancer, 2005, 8 (2) : 111 - 116
  • [50] S-1 with leucovorin and oxaliplatin for advanced gastric cancer
    ter Veer, Emil
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    LANCET ONCOLOGY, 2016, 17 (02): : E41 - E41
12345